Auricular Acupuncture for Analgesia During Total Hip Arthroplasty
NCT ID: NCT00334165
Last Updated: 2011-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2/PHASE3
360 participants
INTERVENTIONAL
2005-06-30
2008-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Auricular acupuncture (procedure)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Surgery time does not exceed 100 minutes.
3. Patients without previous opioid medication.
4. Patients ranged 45-85 years old.
5. Patients who have given informed consent.
Exclusion Criteria
2. Recidivist alcoholics.
3. Local or systemic infection.
4. Age \< 45 and \> 85 years.
5. Surgery time more than 100 minutes.
6. Intraoperative complications (bleeding, required blood transfusion more than 4 units of packed cells , cardiovascular instability, required catecholamines).
7. Patients consumed opioid medication before surgery.
8. Patients with prosthetic or damaged cardiac valves.
9. Patients who are unable to understand the consent form.
10. History of psychiatric disease.
45 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Humboldt-Universität zu Berlin
OTHER
University Medicine Greifswald
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Taras I Usichenko, M.D.
Role: STUDY_CHAIR
Ernst Moritz Arndt University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Berlin, Campus Charite
Berlin, , Germany
Ernst Moritz Arndt University
Greifswald, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
III UV 13/05
Identifier Type: -
Identifier Source: org_study_id